bristol-myers squibb stock news - Search News

Bristol Myers Squibb Stock Rises

Bristol Myers Squibb Vs. AbbVie Stock

Given its better valuation, we believe that Bristol Myers Squibb stock (NYSE: BMY) is currently a better pick than its peer – AbbVie stock .

Why Did Bristol-Myers Squibb Co (BMY) Stock See 34.20% Surge in the Last 90 Days?

On Wednesday, Bristol-Myers Squibb Co (BMY) stock saw a modest uptick, ending the day at $53.76 which represents a slight increase of $0.86 or 1.63% from the prior close of $52.9. The stock opened at $52.

MarketWatch · 7d

Bristol-Myers Squibb stock jumps on schizophrenia drug approval

Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.

2d

Read This Before Considering Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming US$0.60 Dividend

Bristol-Myers Squibb Company ( NYSE:BMY ) stock is about to trade ex-dividend in two days. The ex-dividend date is ...

Investor's Business Daily on MSN19h

Has Consumer Products Giant Bristol-Myers Squibb Kicked Into High Gear?

A Relative Strength Rating upgrade for Bristol Myers Squibb shows improving technical performance. Will it continue?

20h

Bristol-Myers wins FDA nod for Opdivo lung cancer indication

Bristol-Myers Squibb (BMY) wins FDA nod to expand the U.S. label for its blockbuster immunotherapy Opdivo in lung cancer.

3d

Hold Rating on Bristol-Myers Squibb Amid Market Challenges and Strategic Execution Risks

Leerink Partners analyst David Risinger has maintained their neutral stance on BMY stock, giving a Hold rating on September 26. David Risinger ...

3d

Why Prime Medicine Stock Soared Nearly 12% Higher on Monday

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results